Skip to menu Skip to content Skip to footer
Dr Drew Neavin
Dr

Drew Neavin

Email: 

Overview

Background

Dr Drew Neavin is an NHMRC Early Leadership Fellow and the Group Leader of the Context-dependent Genetics Lab at the University of Queensland Institute for Molecular Bioscience.

Drew integrates statistical genetics with stem cell platforms and single-cell technologies to expand our understanding of genetic regulation across different contexts. She helped establish "village-in-a-dish" stem cell systems that enable high-throughput stem cell culture while reducing technical variability by co-culturing induced pluripotent stem cell lines from hundreds of individuals in a single cell culture dish. She applies this system along with other experimental models to study genetic regulation. She works across multiple disease systems with focuses in neuopsychiatric and cardiac, with a special focus on genetic modulation of drug response. She is keen to build large-scale resources that enable population genetics interrogation that consider diversity across multiple different axes.

Availability

Dr Drew Neavin is:
Available for supervision

Works

Search Professor Drew Neavin’s works on UQ eSpace

21 works between 2018 and 2025

21 - 21 of 21 works

2018

Journal Article

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: Metabolomics-informed genomics

Liu, Duan, Ray, Balmiki, Neavin, Drew R., Zhang, Jiabin, Athreya, Arjun P., Biernacka, Joanna M., Bobo, William V., Hall-Flavin, Daniel K., Skime, Michelle K., Zhu, Hongjie, Jenkins, Gregory D., Batzler, Anthony, Kalari, Krishna R., Boakye-Agyeman, Felix, Matson, Wayne R., Bhasin, Swati S., Mushiroda, Taisei, Nakamura, Yusuke, Kubo, Michiaki, Iyer, Ravishankar K., Wang, Liewei, Frye, Mark A., Kaddurah-Daouk, Rima and Weinshilboum, Richard M. (2018). Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: Metabolomics-informed genomics. Translational Psychiatry, 8 (1) 56, 8. doi: 10.1038/s41398-017-0056-8

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: Metabolomics-informed genomics

Funding

Current funding

  • 2026 - 2028
    Building the world's largest bipolar Stem Cell resource to elucidate disease risk and therapy response
    NHMRC IDEAS Grants
    Open grant
  • 2026 - 2030
    Stem cell model systems to reflect global diversity and unlock equitable cardiovascular disease research
    NHMRC Investigator Grants
    Open grant

Supervision

Availability

Dr Drew Neavin is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Dr Drew Neavin's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au